Indian J Pharm Close
 

Figure 13: (a) Activity of SLs on the release of VEGF-A from EA.hy926 cells. Control = 0.5% DMSO and 100 = 100 μg/mL of SLs. (b) Concentration of VEGF-A from EA.hy926 cells. Control = 0.5% DMSO and 100 = 100 μg/mL of SLs. Values shown are presented as mean ± SD (n = 3). **P < 0.01, *P < 0.05, and ns denotes P > 0.05. SLs=Sophorolipids, SD=Standard deviation, VEGF=Vascular endothelial growth factor, ns=Not significant

Figure 13: (a) Activity of SLs on the release of VEGF-A from EA.hy926 cells. Control = 0.5% DMSO and 100 = 100 μg/mL of SLs. (b) Concentration of VEGF-A from EA.hy926 cells. Control = 0.5% DMSO and 100 = 100 μg/mL of SLs. Values shown are presented as mean ± SD (<i>n</i> = 3). **<i>P</i> < 0.01, *<i>P</i> < 0.05, and ns denotes <i>P</i> > 0.05. SLs=Sophorolipids, SD=Standard deviation, VEGF=Vascular endothelial growth factor, ns=Not significant